Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.470
-0.140 (-8.70%)
At close: Nov 20, 2024, 4:00 PM
1.480
+0.010 (0.68%)
After-hours: Nov 20, 2024, 7:38 PM EST
Akari Therapeutics, Statistics
Total Valuation
AKTX has a market cap or net worth of $17.57 million. The enterprise value is $16.33 million.
Market Cap | 17.57M |
Enterprise Value | 16.33M |
Important Dates
The last earnings date was Tuesday, November 19, 2024, after market close.
Earnings Date | Nov 19, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AKTX has 11.95 million shares outstanding. The number of shares has increased by 86.15% in one year.
Current Share Class | n/a |
Shares Outstanding | 11.95M |
Shares Change (YoY) | +86.15% |
Shares Change (QoQ) | +29.46% |
Owned by Insiders (%) | 52.41% |
Owned by Institutions (%) | 1.74% |
Float | 5.27M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.29
Current Ratio | 0.29 |
Quick Ratio | 0.24 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -145.35 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -307.55% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.68M |
Employee Count | 12 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.06% in the last 52 weeks. The beta is 0.95, so AKTX's price volatility has been similar to the market average.
Beta (5Y) | 0.95 |
52-Week Price Change | -54.06% |
50-Day Moving Average | 2.63 |
200-Day Moving Average | 2.54 |
Relative Strength Index (RSI) | 27.40 |
Average Volume (20 Days) | 36,265 |
Short Selling Information
Short Interest | 21,291 |
Short Previous Month | 18,456 |
Short % of Shares Out | 0.23% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.92 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -17.44M |
Pretax Income | n/a |
Net Income | -20.16M |
EBITDA | -17.43M |
EBIT | -17.44M |
Earnings Per Share (EPS) | -$2.46 |
Balance Sheet
The company has $2.25 million in cash and $1.00 million in debt, giving a net cash position of $1.25 million or $0.10 per share.
Cash & Cash Equivalents | 2.25M |
Total Debt | 1.00M |
Net Cash | 1.25M |
Net Cash Per Share | $0.10 |
Equity (Book Value) | -6.69M |
Book Value Per Share | -0.55 |
Working Capital | -6.69M |
Cash Flow
Operating Cash Flow | -14.84M |
Capital Expenditures | n/a |
Free Cash Flow | -14.84M |
FCF Per Share | -$1.24 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AKTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -86.15% |
Shareholder Yield | -86.15% |
Earnings Yield | -114.71% |
FCF Yield | -84.44% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 17, 2023. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Aug 17, 2023 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |